Showing results (1991-2000 of 2,037) with videos related to

Sort By:
Pageof 204
Nuklearmedizin. Nuclear Medicine|February 28, 2023
The value of radioembolisation therapy on metastatic liver tumours - a single centre experienceOzgul Ekmekcioglu, Umut Erdem, Pelin Arican, et al.
Nuklearmedizin. Nuclear Medicine|August 20, 2021
Are radiopharmaceuticals self-sterilizing? Radiation effect of gallium-68 and lutetium-177 on bacillus pumilus and staphylococcus succinusSimon Poetzsch, Winfried Brenner, Sarah Spreckelmeyer
Nuklearmedizin. Nuclear Medicine|August 1, 1987
Fatty acid metabolism in symptomatic patients with mitral valve prolapse but without coronary artery disease--comparison with 201Tl myocardial perfusion scintigraphyE Voth, H Schicha, U Tebbe, et al.
Nuklearmedizin. Nuclear Medicine|November 26, 2025
Targeting TROP-2 in Prostate Cancer Using Site-Specifically Radiolabeled IMMU-132 with ⁸⁹Zr via 3,4,3-LI(1,2-HOPO)Syed Qaiser Shah, Ralph Santos-Oliveira, DeryaIlem Ozdemir, et al.
Nuklearmedizin. Nuclear Medicine|November 24, 2025
Myocardial Perfusion SPECT 2024 in Germany: Results of the 10th SurveyOliver Lindner, Matthias Gutberlet, Wolfgang Burchert, et al.
Nuklearmedizin. Nuclear Medicine|August 2, 2022
Distribution of Functional Status of Thyroid Nodules and Malignancy Rates of Hyperfunctioning and Hypofunctioning Thyroid Nodules in GermanySimone Agnes Schenke, Michael C Kreissl, Michael Grunert, et al.
Nuklearmedizin. Nuclear Medicine|February 1, 1983
Scintigraphic myocardial imaging with 99mTc-labelled gluconate of experimentally produced cardiomyopathy in dogsF Duska, J Novák, Y Mazurová, et al.
Nuklearmedizin. Nuclear Medicine|April 1, 1983
[Effect of the plan of therapy on prognosis in thyroid cancer]C Schümichen, E Schmitt, C Scheuffele, et al.
Nuklearmedizin. Nuclear Medicine|October 1, 1981
Loss of thyroid hormones into feces in children on regular hemodialysisW Waters
Nuklearmedizin. Nuclear Medicine|August 6, 2025
Overview of selected completed prospective studies on PSMA-targeted radioligand therapy with [177Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancerAmir Karimzadeh, Wencke Lehnert, Daniel Koehler, et al.
Pageof 204